Lialda and Enbrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lialda (mesalamine) and Enbrel (etanercept). Common drug interactions include pneumonia among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Lialda and Enbrel. It is created by eHealthMe based on reports of 80 people who take the same drugs from the FDA, and is updated regularly.

What is Lialda?

Lialda has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 10,199 Lialda users. Check the latest studies of Lialda.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.



On Aug, 13, 2026

80 people who take Lialda and Enbrel together, and have interactions are studied.

Lialda and Enbrel drug interactions.

What are the common drug interactions of Lialda and Enbrel, by gender? *:

female:

  1. Pneumonia
  2. Rectal cancer (cancer of rectum)
  3. Thyroid neoplasm (tumour of thyroid)
  4. Ulcer
  5. Activities of daily living impaired
  6. Adverse drug reaction
  7. Dehydration (dryness resulting from the removal of water)
  8. Feeling cold
  9. Fistula (an abnormal connection or passageway between two)
  10. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins)

male:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Drug effect decreased
  3. Arthropathy
  4. Asthma
  5. Depressed mood
  6. Injection site pruritus (severe itching at injection site)
  7. Injection site swelling
  8. Lung infection
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Rhinorrhoea (watery mucus discharge from the nose)

What are the common drug interactions of Lialda and Enbrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Injection site bruising
  2. Oral infection

20-29:

n/a

30-39:

  1. Depressed mood
  2. Injection site bruising
  3. Injection site pain
  4. Injection site pruritus (severe itching at injection site)
  5. Injection site swelling

40-49:

  1. Drug ineffective
  2. Pain
  3. Pain in extremity
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Peripheral swelling
  6. Stress

50-59:

  1. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  2. Prostatitis (inflammation of the prostate gland)
  3. Rhinorrhoea (watery mucus discharge from the nose)
  4. Skin cancer
  5. Activities of daily living impaired
  6. Dehydration (dryness resulting from the removal of water)
  7. Drug effect decreased
  8. Feeling cold
  9. Fistula (an abnormal connection or passageway between two)
  10. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins)

60+:

  1. Arthralgia (joint pain)
  2. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Diarrhoea
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dysphoria (generalized dissatisfaction with life)
  7. Ear pain
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Haemorrhagic diathesis (bleeding tendency)

What are the existing conditions these people have? *

  1. Dizziness: 36 people, 45.00%
  2. Pain: 16 people, 20.00%
  3. Psoriasis (immune-mediated disease that affects the skin): 11 people, 13.75%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 10.00%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lialda and Enbrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lialda and Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lialda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lialda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enbrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and etanercept (the active ingredients of Lialda and Enbrel, respectively), and Lialda and Enbrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: